The importance of p53 in human cancer is emphasised by observations that p53 is mutated in up to half of all malignancies, whilst aberrant upstream or downstream p53 pathways, including MDM2 amplification and p14ARF inactivation are common events in p53 wild-type (wt) cancers [2]. Here, MDM2 is linked to cancer.